If You Invested $10K In CareTrust REIT Stock 10 Years Ago, How Much Would You Have Now?
If You Invested $10K In CareTrust REIT Stock 10 Years Ago, How Much Would You Have Now?
If You Invested $10K In CareTrust REIT Stock 10 Years Ago, How Much Would You Have Now?

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

CareTrust REIT (NYSE:CTRE) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector.

It is set to report its Q1 2025 earnings on May 1. Wall Street analysts expect the company to post EPS of $0.43, up from $0.35 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $98.85 million, up from $63.07 million a year earlier.

Don't Miss:

If You Bought CareTrust REIT Stock 10 Years Ago

The company's stock traded at approximately $13.46 per share 10 years ago. If you had invested $10,000, you could have bought roughly 743 shares. Currently, shares trade at $26.65, meaning your investment's value could have grown to $19,799 from stock price appreciation alone. However, CareTrust REIT also paid dividends during these 10 years.

CareTrust REIT's dividend yield is currently 5.03%. Over the last 10 years, it has paid about $11.40 in dividends per share, which means you could have made $8,470 from dividends alone.

Summing up $19,799 and $8,470, we end up with the final value of your investment, which is $28,269. This is how much you could have made if you had invested $10,000 in CareTrust REIT stock 10 years ago. This means a total return of 182.69%. In comparison, S&P 500 total return for the same period is 183.50%.

Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.

What Could The Next 10 Years Bring?

CareTrust REIT has a consensus rating of "Overweight" and a price target of $26.14 based on the ratings of 14 analysts. The price target implies a nearly 2% potential downside from the current stock price.

On Feb. 12, the company announced its Q4 2024 earnings, posting EPS of $0.40, compared to the consensus estimate of $0.31, and revenues of $86.94 million, compared to the consensus of $67.95 million, as reported by Benzinga.

“We finished a record year with a record quarter. Now all eyes are on 2025 and beyond," said CEO Dave Sedgwick. "We continue to position the company to build on the momentum of impactful growth with top-tier operators. Our balance sheet, access to capital, team, partnerships, and opportunities to grow and diversify the portfolio are all in a stronger position than they were twelve months ago."